We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.

Institute for Diabetes Research and Metabolic Diseases

Universität Tübingen

The primary research objective of the Institute for Diabetes Research and Metabolic Diseases (IDM) is personalized prediction of diabetes risk as well as diabetes prevention and personalized therapy. Studies of gene-environment interaction are the main focus. Through the establishment of very well phenotyped cohort studies with more than 2,500 participants with an increased risk of diabetes, the Institute in Tübingen has great expertise in the prediction and prevention of type 2 diabetes and its complications.


Research groups

  • Prevention and Therapy of Typ-2 Diabetes: Prof. Dr. Andreas Fritsche, Dr. Martin Heni
  • Pathophysiology of Prediabetes: Prof. Dr. Norbert Stefan, Prof. Dr. Dr. Fritz Schick
  • Behavioural Neurobiology and Metabolism: Prof. Dr. Jan Born, Prof. Dr. Manfred Hallschmid
  • Metabolic Imaging: Prof. Dr. Claus Claussen
  • Molecular Diabetology: Prof. Dr. Cora Weigert
  • Metabolic Neuroimaging: Prof. Dr. Hubert Preißl, Dr. Stephanie Kullmann
  • Translational Diabetology: Prof. Dr. Harald Staiger, Dr. Anna-Maria Ordelheide
  • DZD Clinical Chemistry Lab: Prof. Dr. Andreas Peter, Prof. Dr. Erwin Schleicher
  • DZD Islet Facility: Prof. Dr. Susanne Ullrich


Contribution to the DZD research program

  • Head of the German pre-diabetes intervention study to develop personalized diabetes prevention strategies
  • Development and application of new non-invasive methods for assessing individual risk of diabetes and personalized diabetes prevention and therapy
  • Systematic analysis of blood metabolites to identify early markers of impaired glucose metabolism and assess their potential for clinical diabetes prediction
  • Studies on the role of the brain in the regulation of appetite, exercise, insulin sensitivity, insulin secretion and ectopic fat accumulation in tissue
  • Participation in further clinical studies of the DZD


Prof. Dr. Dr. h.c. mult. Hans-Ulrich Häring

Medical Director of Medical Clinic IV of the University of Tübingen


Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Zentrum München at the Eberhard-Karls-University of Tuebingen
Otfried-Müller-Str. 10
72076 Tübingen

+49 (0)7071 2985669